OLMA
Olema Pharmaceuticals, Inc.
14.53
USD
This page is just a preview of the data found in TrendSpider’s full version
Olema Pharmaceuticals, Inc. stock is down -7.69% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November. In the last 6 Unusual Options Trades, there were 6 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 03 Oct 15:34 | 19 Jan, 2024 | 12.50 | 1007 | ||
| 03 Oct 16:01 | 19 Jan, 2024 | 12.50 | 1007 | ||
| 18 Oct 19:48 | 19 Jan, 2024 | 10.00 | 218 | ||
| 19 Oct 17:48 | 19 Jan, 2024 | 10.00 | 459 | ||
| 19 Oct 18:40 | 19 Jan, 2024 | 10.00 | 459 | ||
| 21 Nov 17:06 | 19 Jan, 2024 | 15.00 | 54 |
Olema Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of therapies for women's cancers. OP-1250, an estrogen receptor antagonist and a selective ER degrader, is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.
